| Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature MK Frey, B Pothuri Gynecologic oncology research and practice 4, 1-11, 2017 | 142 | 2017 |
| Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer MK Frey, AE Ellis, K Zeligs, E Chapman-Davis, C Thomas, PJ Christos, ... American journal of obstetrics and gynecology 223 (5), 725. e1-725. e9, 2020 | 122 | 2020 |
| Racial and ethnic disparities in genetic testing at a hereditary breast and ovarian cancer center E Chapman-Davis, ZN Zhou, JC Fields, MK Frey, B Jordan, KJ Sapra, ... Journal of General Internal Medicine 36, 35-42, 2021 | 111 | 2021 |
| Primary lymphoma of the female genital tract: an analysis of 697 cases D Nasioudis, PN Kampaktsis, M Frey, SS Witkin, K Holcomb Gynecologic oncology 145 (2), 305-309, 2017 | 95 | 2017 |
| Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch … RM Kahn, S Gordhandas, BP Maddy, B Baltich Nelson, G Askin, ... Cancer 125 (18), 3172-3183, 2019 | 85 | 2019 |
| Cascading after peridiagnostic cancer genetic testing: an alternative to population-based screening K Offit, KA Tkachuk, ZK Stadler, MF Walsh, H Diaz-Zabala, JD Levin, ... Journal of Clinical Oncology 38 (13), 1398, 2020 | 77 | 2020 |
| Prospective feasibility trial of a novel strategy of facilitated cascade genetic testing using telephone counseling MK Frey, RM Kahn, E Chapman-Davis, F Tubito, M Pires, P Christos, ... Journal of Clinical Oncology 38 (13), 1389, 2020 | 62 | 2020 |
| Lymphatic ascites following pelvic and paraaortic lymphadenectomy procedures for gynecologic malignancies MK Frey, NM Ward, TA Caputo, J Taylor, MJ Worley Jr, BM Slomovitz Gynecologic oncology 125 (1), 48-53, 2012 | 57 | 2012 |
| Achieving universal genetic assessment for women with ovarian cancer: are we there yet? A systematic review and meta-analysis J Lin, RN Sharaf, R Saganty, D Ahsan, J Feit, A Khoury, H Bergeron, ... Gynecologic oncology 162 (2), 506-516, 2021 | 53 | 2021 |
| Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening MK Frey, SH Kim, RY Bassett, J Martineau, E Dalton, JY Chern, SV Blank Gynecologic oncology 139 (2), 211-215, 2015 | 51 | 2015 |
| Cascade testing for hereditary cancer syndromes: should we move toward direct relative contact? A systematic review and meta-analysis MK Frey, MD Ahsan, H Bergeron, J Lin, X Li, RK Fowlkes, P Narayan, ... Journal of Clinical Oncology 40 (35), 4129-4143, 2022 | 49 | 2022 |
| Risk-reducing bilateral salpingo-oophorectomy for ovarian cancer: a review and clinical guide for hereditary predisposition genes YL Liu, K Breen, A Catchings, M Ranganathan, A Latham, DJ Goldfrank, ... JCO oncology practice 18 (3), 201-209, 2022 | 48 | 2022 |
| Learning curve analysis of the first 100 robotic-assisted laparoscopic hysterectomies performed by a single surgeon JF Lin, M Frey, JQ Huang International Journal of Gynecology & Obstetrics 124 (1), 88-91, 2014 | 48 | 2014 |
| Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidity KC Long, EJ Tanner, M Frey, MM Leitao Jr, DA Levine, GJ Gardner, ... Gynecologic oncology 131 (3), 525-530, 2013 | 48 | 2013 |
| Genetic testing for all: overcoming disparities in ovarian cancer genetic testing MK Frey, A Finch, A Kulkarni, MR Akbari, E Chapman-Davis American Society of Clinical Oncology Educational Book 42, 471-482, 2022 | 47 | 2022 |
| The safety of same-day discharge after laparoscopic hysterectomy for endometrial cancer J Lee, Y Aphinyanaphongs, JP Curtin, JY Chern, MK Frey, LR Boyd Gynecologic oncology 142 (3), 508-513, 2016 | 47 | 2016 |
| Fertility-preserving surgery for advanced stage ovarian germ cell tumors D Nasioudis, MK Frey, E Chapman-Davis, TA Caputo, K Holcomb Gynecologic Oncology 147 (3), 493-496, 2017 | 46 | 2017 |
| Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma D Nasioudis, E Chapman-Davis, M Frey, K Holcomb Journal of gynecologic oncology 28 (4), 2017 | 45 | 2017 |
| Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals MK Frey, RK Fowlkes, NM Badiner, D Fishman, M Kanis, C Thomas, ... Gynecologic oncology 159 (2), 470-475, 2020 | 43 | 2020 |
| Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base D Nasioudis, E Chapman-Davis, MK Frey, TA Caputo, K Holcomb Gynecologic Oncology 147 (2), 296-301, 2017 | 43 | 2017 |
